TY - JOUR
T1 - Role of curcumin and its nanoformulations in the treatment of neurological diseases through the effects on stem cells
AU - Sabouni, Nasim
AU - Marzouni, Hadi Zare
AU - Palizban, Sepideh
AU - Meidaninikjeh, Sepideh
AU - Kesharwani, Prashant
AU - Jamialahmadi, Tannaz
AU - Sahebkar, Amirhossein
PY - 2023
Y1 - 2023
N2 - Curcumin from turmeric is a natural phenolic compound with a promising potential to regulate fundamental processes involved in neurological diseases, including inflammation, oxidative stress, protein aggregation, and apoptosis at the molecular level. In this regard, employing nanoformulation can improve curcumin efficiency by reducing its limitations, such as low bioavailability. Besides curcumin, growing data suggest that stem cells are a noteworthy candidate for neurodegenerative disorders therapy due to their anti-inflammatory, anti-oxidative, and neuronal-differentiation properties, which result in neuroprotection. Curcumin and stem cells have similar neurogenic features and can be co-administered in a cell-drug delivery system to achieve better combination therapeutic outcomes for neurological diseases. Based on the evidence, curcumin can induce the neuroprotective activity of stem cells by modulating their related signalling pathways. The present review is about the role of curcumin and its nanoformulations in the improvement of neurological diseases alone and through the effect on different categories of stem cells by discussing the underlying mechanisms to provide a roadmap for future investigations.
AB - Curcumin from turmeric is a natural phenolic compound with a promising potential to regulate fundamental processes involved in neurological diseases, including inflammation, oxidative stress, protein aggregation, and apoptosis at the molecular level. In this regard, employing nanoformulation can improve curcumin efficiency by reducing its limitations, such as low bioavailability. Besides curcumin, growing data suggest that stem cells are a noteworthy candidate for neurodegenerative disorders therapy due to their anti-inflammatory, anti-oxidative, and neuronal-differentiation properties, which result in neuroprotection. Curcumin and stem cells have similar neurogenic features and can be co-administered in a cell-drug delivery system to achieve better combination therapeutic outcomes for neurological diseases. Based on the evidence, curcumin can induce the neuroprotective activity of stem cells by modulating their related signalling pathways. The present review is about the role of curcumin and its nanoformulations in the improvement of neurological diseases alone and through the effect on different categories of stem cells by discussing the underlying mechanisms to provide a roadmap for future investigations.
KW - Curcumin
KW - nanoformulation
KW - neurological disease
KW - stem cells
KW - neuroprotective
KW - combination therapy
KW - OLFACTORY ENSHEATHING CELLS
KW - SPINAL-CORD-INJURY
KW - PROGRESSIVE MULTIPLE-SCLEROSIS
KW - CELLULAR STRESS-RESPONSE
KW - NEURAL PRECURSOR CELLS
KW - MEMBRANE REDOX SYSTEM
KW - OXIDATIVE STRESS
KW - PARKINSONS-DISEASE
KW - EXPERIMENTAL-MODEL
KW - DRUG-DELIVERY
UR - http://www.scopus.com/inward/record.url?scp=85143804932&partnerID=8YFLogxK
UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000888952500001
U2 - 10.1080/1061186X.2022.2141755
DO - 10.1080/1061186X.2022.2141755
M3 - Review article
C2 - 36305097
SN - 1061-186X
VL - 31
SP - 243
EP - 260
JO - Journal of Drug Targeting
JF - Journal of Drug Targeting
IS - 3
ER -